Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs

In China, progress to include the RV vaccine in the national immunization program (NIP) is slow. The only two vaccines, the Lanzhou lamb rotavirus vaccine (LLR) and Rotateq, are provided through the private market. This study aims to assess the health impact and cost-effectiveness of using three vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiahao, Zhang, Haijun, Zhang, Haonan, Fang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Rotavirus – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019831/
https://www.ncbi.nlm.nih.gov/pubmed/35816415
http://dx.doi.org/10.1080/21645515.2022.2090162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019831/
https://www.ncbi.nlm.nih.gov/pubmed/35816415
http://dx.doi.org/10.1080/21645515.2022.2090162

Ejemplares similares